Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Insights into the bone morphogenetic protein signaling in musculoskeletal disorders: Mechanisms and crosstalk

Chen B., Liu X., Hu M., Liao J.

Narrative Review on Osteoarthritis, Autoimmune Research, published in J Orthop Translat (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Orthop Translat (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40485850
PMCID
PMC12145526
DOI
10.1016/j.jot.2025.03.005
Citations
2

Abstract (original English)

Musculoskeletal disorders are age-related illnesses that substantially impact the locomotor system. These problems can lead to serious complications, such as fractures, which can severely compromise the quality of life of patients. With the aging of the global population, the incidence and prevalence of musculoskeletal disorders are gradually increasing. Proliferation, differentiation, and cellular fate are extensively regulated by the BMP signaling pathway, which is expressed in approximately all organ systems. Musculoskeletal diseases are generally influenced by BMP signaling, which impedes the degeneration of musculoskeletal diseases. In this review, the pathophysiological functions of BMP signaling in four main musculoskeletal disorders (osteoporosis, osteoarthritis, rheumatoid arthritis, and sarcopenia) are summarized, and the role of cross talk between BMP signaling and other signaling pathways in the development of musculoskeletal disorders is reviewed. Finally, a conclusion regarding research on the role of BMP signaling in musculoskeletal disorders is formulated. Targeting the BMP signaling pathway is a promising therapeutic approach, and related studies have offered insights into the pathophysiological mechanism of musculoskeletal disorders. The translational potential of this article The identification of the BMP signaling pathway involved in the development of muscu

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research